Cargando…

Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors

PURPOSE: The purpose of this retrospective study was to identify the independent prognostic factors and optimize the treatment for nasopharyngeal carcinoma (NPC) patients with distant metastasis at initial diagnosis. METHODS: A total of 234 patients referred between January 2001 and December 2010 we...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Lei, Tian, Yun-Ming, Huang, Ying, Sun, Xue-Ming, Wang, Feng-Hua, Deng, Xiao-Wu, Han, Fei, Lu, Tai-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172685/
https://www.ncbi.nlm.nih.gov/pubmed/25247415
http://dx.doi.org/10.1371/journal.pone.0108070
_version_ 1782336058066731008
author Zeng, Lei
Tian, Yun-Ming
Huang, Ying
Sun, Xue-Ming
Wang, Feng-Hua
Deng, Xiao-Wu
Han, Fei
Lu, Tai-Xiang
author_facet Zeng, Lei
Tian, Yun-Ming
Huang, Ying
Sun, Xue-Ming
Wang, Feng-Hua
Deng, Xiao-Wu
Han, Fei
Lu, Tai-Xiang
author_sort Zeng, Lei
collection PubMed
description PURPOSE: The purpose of this retrospective study was to identify the independent prognostic factors and optimize the treatment for nasopharyngeal carcinoma (NPC) patients with distant metastasis at initial diagnosis. METHODS: A total of 234 patients referred between January 2001 and December 2010 were retrospectively analyzed. Among the 234 patients, 94 patients received chemotherapy alone (CT), and 140 patients received chemoradiotherapy (CRT). Clinical features, laboratory parameters and treatment modality were examined with univariate and multivariate analyses. RESULTS: The median overall survival (OS) time was 22 months (range, 2-125 months), and the 1-year, 2-year, 3-year overall survival rates were 82.2%, 51.3% and 34.1%. The overall response and disease control rates of metastatic lesions after chemotherapy were 56.0% and 89.8%. The factors associated with poor response were karnofsky performance score (KPS) <80, liver metastasis, lactate dehydrogenase (LDH)>245 IU/L, and number of chemotherapy cycles <4. The 3-year OS of patients receiving CRT was higher than those receiving CT alone (48.2% vs. 12.4%, p<0.001). Subgroup analysis showed that significantly improved survival was also achieved by radiotherapy of the primary tumor in patients who achieved complete remission (CR)/partial remission (PR) or stable disease (SD) of metastatic lesions after chemotherapy. Significant independent prognostic factors of OS were KPS, liver metastasis, levels of LDH, and multiple metastases. Treatment modality, response to chemotherapy and chemotherapy cycles were also associated with OS. CONCLUSION: A combination of radiotherapy and chemotherapy seems to have survival benefits for selected patients with distant metastases at initial diagnosis. Clinical and laboratory characteristics can help to guide treatment selection. Prospective randomized studies are needed to confirm the result.
format Online
Article
Text
id pubmed-4172685
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41726852014-10-02 Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors Zeng, Lei Tian, Yun-Ming Huang, Ying Sun, Xue-Ming Wang, Feng-Hua Deng, Xiao-Wu Han, Fei Lu, Tai-Xiang PLoS One Research Article PURPOSE: The purpose of this retrospective study was to identify the independent prognostic factors and optimize the treatment for nasopharyngeal carcinoma (NPC) patients with distant metastasis at initial diagnosis. METHODS: A total of 234 patients referred between January 2001 and December 2010 were retrospectively analyzed. Among the 234 patients, 94 patients received chemotherapy alone (CT), and 140 patients received chemoradiotherapy (CRT). Clinical features, laboratory parameters and treatment modality were examined with univariate and multivariate analyses. RESULTS: The median overall survival (OS) time was 22 months (range, 2-125 months), and the 1-year, 2-year, 3-year overall survival rates were 82.2%, 51.3% and 34.1%. The overall response and disease control rates of metastatic lesions after chemotherapy were 56.0% and 89.8%. The factors associated with poor response were karnofsky performance score (KPS) <80, liver metastasis, lactate dehydrogenase (LDH)>245 IU/L, and number of chemotherapy cycles <4. The 3-year OS of patients receiving CRT was higher than those receiving CT alone (48.2% vs. 12.4%, p<0.001). Subgroup analysis showed that significantly improved survival was also achieved by radiotherapy of the primary tumor in patients who achieved complete remission (CR)/partial remission (PR) or stable disease (SD) of metastatic lesions after chemotherapy. Significant independent prognostic factors of OS were KPS, liver metastasis, levels of LDH, and multiple metastases. Treatment modality, response to chemotherapy and chemotherapy cycles were also associated with OS. CONCLUSION: A combination of radiotherapy and chemotherapy seems to have survival benefits for selected patients with distant metastases at initial diagnosis. Clinical and laboratory characteristics can help to guide treatment selection. Prospective randomized studies are needed to confirm the result. Public Library of Science 2014-09-23 /pmc/articles/PMC4172685/ /pubmed/25247415 http://dx.doi.org/10.1371/journal.pone.0108070 Text en © 2014 Zeng et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zeng, Lei
Tian, Yun-Ming
Huang, Ying
Sun, Xue-Ming
Wang, Feng-Hua
Deng, Xiao-Wu
Han, Fei
Lu, Tai-Xiang
Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors
title Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors
title_full Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors
title_fullStr Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors
title_full_unstemmed Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors
title_short Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors
title_sort retrospective analysis of 234 nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis: therapeutic approaches and prognostic factors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172685/
https://www.ncbi.nlm.nih.gov/pubmed/25247415
http://dx.doi.org/10.1371/journal.pone.0108070
work_keys_str_mv AT zenglei retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors
AT tianyunming retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors
AT huangying retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors
AT sunxueming retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors
AT wangfenghua retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors
AT dengxiaowu retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors
AT hanfei retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors
AT lutaixiang retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors